|
|
.
See Category: Neoplasms
See Header: Secondary carcinoid tumors
ICD-10 (CM) Code and Descriptor
|
C7B.04 |
Secondary carcinoid tumors of peritoneum
|
C7B04 utilizaton on OPPS claims.*
Primary
ICD10 Code |
ICD10
Position 2 |
ICD10
Position 3 |
ICD10
Position 4 |
ICD10
Position 5 |
ICD10
Position 6 |
ICD10
Position 7 |
ICD10
Position 8 |
ICD10
Position 9 |
ICD10
Position 10 |
| 6.82%
|
28.35%
|
27.14%
|
17.33%
|
7.61%
|
2.87%
|
4.03%
|
1.50%
|
1.95%
|
0.71%
|
* Medicare Part A utilization data is derived from the 100% 2023 Outpatient (Fee-for-Service) Standard Analytical File.
Commonly Associated Procedure Codes for C7B.04*:
| CPT |
Description |
Number of Claims |
Sum Performed |
|
80053
|
COMPREHEN METABOLIC PANEL |
62
|
62
|
|
85025
|
COMPLETE CBC W/AUTO DIFF WBC |
57
|
57
|
|
96372
|
THER/PROPH/DIAG INJ SC/IM |
56
|
57
|
|
36415
|
COLL VENOUS BLD VENIPUNCTURE |
51
|
52
|
|
G0463
|
HOSPITAL OUTPT CLINIC VISIT |
51
|
51
|
|
J2353
|
OCTREOTIDE INJECTION, DEPOT |
38
|
1,080
|
|
86316
|
IMMUNOASSAY TUMOR OTHER |
29
|
31
|
|
97530
|
THERAPEUTIC ACTIVITIES |
22
|
27
|
|
97110
|
THERAPEUTIC EXERCISES |
22
|
23
|
|
A9513
|
LUTETIUM LU 177 DOTATAT THER |
16
|
1,993
|
|
Q9967
|
LOCM 300-399MG/ML IODINE,1ML |
15
|
1,747
|
|
84260
|
ASSAY OF SEROTONIN |
15
|
15
|
|
J1930
|
LANREOTIDE INJECTION |
14
|
1,680
|
|
97112
|
NEUROMUSCULAR REEDUCATION |
14
|
16
|
|
83735
|
ASSAY OF MAGNESIUM |
14
|
14
|
|
84100
|
ASSAY OF PHOSPHORUS |
11
|
11
|
|
74177
|
CT ABD & PELVIS W/CONTRAST |
10
|
10
|
|
79101
|
NUCLEAR RX IV ADMIN |
9
|
9
|
|
J3420
|
VITAMIN B12 INJECTION |
8
|
8
|
|
82728
|
ASSAY OF FERRITIN |
8
|
8
|
* Derived from 100% 2021 Outpatient (Fee-for-Service) Standard Analytical File.
C7B.04 related to the following DRG Codes:
374-376
|
